TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
3月 20, 2026
2 min read
15

UBS Switzerland AG’s Chief Investment Office anticipates sustained positive earnings growth for Swiss equities, highlighting an attractive dividend yield of over 3% in the current market environment. This outlook persists despite challenges from geopolitical tensions and evolving US trade policies.
Global equity markets are currently influenced by geopolitical uncertainty and the rapid integration of artificial intelligence across various sectors. This has led to a market rotation, with investors reallocating capital based on perceived AI impact. UBS notes that while AI will drive significant economic change, recent market shifts may have been overly broad.
UBS recommends a focus on quality companies, profitability leaders, and select mid-cap and cyclical stocks. The bank suggests tactically reducing exposure to pharmaceutical stocks and buying oversold companies in AI-affected sectors. UBS maintains a central scenario target of 14,000 for the SMI index by December 2026.
Despite short-term volatility and negative currency effects, UBS views attractively valued yield stocks with dividend growth as a primary investment theme. Swiss dividends have shown consistent growth, reinforcing the market's appeal for long-term investors.
Q: What is the main attraction of Swiss equities according to UBS?
A: Their sustainable dividend yield of just over 3% and continued prospects for positive earnings growth.
Q: What is UBS's target for the SMI index?
A: UBS has set a central scenario target of 14,000 for the SMI by December 2026.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles